10/9/2017 OBJECTIVES DIABETES REVIEW

Size: px
Start display at page:

Download "10/9/2017 OBJECTIVES DIABETES REVIEW"

Transcription

1 OBJECTIVES MECHANICAL MADNESS: TECHNOLOGY, DIABETES AND PREGNANCY ALYSON BLUM, PHARMD, CDE CLINICAL PHARMACIST IN OBSTETRICS SACRED HEART MEDICAL CENTER, CENTER FOR MATERNAL FETAL MEDICINE WASHINGTON STATE UNIVERSITY Review the different types of diabetes Review pregnancy implications of uncontrolled diabetes Discuss the role of insulin pumps and continuous glucose monitors (CGM) in pregnancy Type 1 Diabetes Autoimmune disease Don t make any insulin Must have exogenous insulin to survive Usually diagnosed in childhood Not a disease of insulin resistance Type 2 Diabetes Generally a disease of insulin resistance Makes extra insulin May need exogenous insulin with disease progression Usually diagnosed in adulthood Associated with metabolic disturbances Type 1.5 Diabetes (LADA) Latent autoimmune diabetes of adults Don t make enough insulin to manage blood glucose Insulin resistance varies Diagnosed in early adulthood 1 st pregnancy can often be the trigger Gestational Diabetes Disease of resistance related to hormones of pregnancy Diagnosed after 1 st trimester Increases risk of developing type 2 diabetes by 50% in the next 10 years 1

2 FETAL IMPLICATIONS Uncontrolled diabetes in the 1 st trimester Congenital anomalies Heart defects Musculoskeletal defects Pregnancy loss Type 1, Type 2 and Type 1.5 are at highest risk FETAL IMPLICATIONS Uncontrolled diabetes in the 2 nd and 3 rd trimesters Macrosomia Jaundice Hypoglycemia of the newborn Preterm delivery Neonatal RDS, polycythemia or hypothermia Still birth Lifelong struggles with obesity and diabetes All types of diabetes BLOOD GLUCOSE GOALS IN PREGNANCY TREATMENT OPTIONS IN PREGNANCY Test Time ACOG/ADA Sweet Success/MFM Fasting <95mg/dL <90mg/dL 1 hour post prandial <140mg/dL <120mg/dL 2 hour post prandial <120mg/dL Metformin Increases insulin sensitivity Decreases glucose release from the liver Type 1, 1.5, 2 and gestational diabetes Glyburide Cheerleader for the pancreases Forces insulin secretion Type 2 and gestational diabetes INSULIN IN PREGNANCY INSULIN IN PREGNANCY Long Acting Levemir (twice daily dosing) Lantus (once daily) Toujeo U300 (one daily) Tresiba U100 or U200 (once daily) Short Acting Humalog (U100 or U200) Novolog (U100) Humulin R (U100) Intermediate Acting NPH (twice daily) Humulin R (U500) Inhaled insulin Not approved in pregnancy New FDA approvals ultra rapid acting Humalog Novolog Patient centered regimens Long and/or short acting Concentrated or not Set dosing or insulin to carb ratio Pumps and CGMs 2

3 INSULIN PUMPS INSULIN PUMPS Continuously delivers insulin under the skin and can be programed to calculate and deliver a bolus for meals and high blood glucose Place pump sites at acceptable injections sites Many 3 kinds of pumps Type 1, 1.5 and 2 diabetes controlled or uncontrolled CONTINUOUS GLUCOSE MONITORS Not approved in pregnancy (not tested) Only approved to place on abdomen (patients put it almost everywhere) Changed every 7 14 days Calibrated 0 4 times daily CONTINUOUS GLUCOSE MONITORS (CGM) ADVANTAGES OF PUMPS AND CGMS Barriers to meeting blood glucose goals Too many injections needed for good control Withholding carbs to avoid additional injections Inability to have a consistent diet Too many finger sticks (up to 10 times daily) Embarrassment issues Pumps and CGMs address all these issues ADVANTAGES OF PUMPS AND CGMS Too many injections needed for good control 1 new site (injection) every 3 days Withholding carbs to avoid additional injections Can dose for all carbs without extra work Inability to have a consistent diet Pump is programed with and insulin:carb ratio and correction factor tailored to the patient. Can have small meals or large meals Need to count carbs 3

4 ADVANTAGES OF PUMPS AND CGMS DISADVANTAGES OF PUMPS AND CGMS Too many finger sticks CGMs are replaced every 7 14 days Calibrate (requires finger stick) 2 4 times daily Embarrassment issues Blood sugar can be seen on phone Pumps are discrete and dosing can be done very quickly Higher chance of DKA Requires interaction/connection to diabetes Can break/malfunction CGMs are 15 min behind actual blood glucose. CGMS ARE BEHIND BLOOD GLUCOSE? Direction and velocity 120mg/dL Not changing See trend graph? Was dropping but has now leveled out EXAMPLE 95mg/dL is a great number (on a meter) Slight arrow up (increasing by >1 point/min) Arrow straight up (increasing by 2 points/min) PATIENT CASE: HOW USEFUL ARE CGMS? AC is a 42 year old G 5 P 3 Was with me in her previous pregnancy when she was diagnosed with type 1.5 diabetes. Put her on a pump and CGM Repeat CS in 2016 Texts me that she just had a positive home pregnancy test. Still had her Dexcom Share Data Code 4

5 We made first adjustments over the phone and after 1 week: This was able to be done remotely, before she even made it to the office. Better for baby Better for mom 5

6 CONCLUSIONS QUESTIONS? Uncontrolled diabetes has poor maternal and fetal outcomes. Pumps and CGMs have a role in pre existing diabetes. Better control can be obtained in these patient populations with CGMs and pumps REFERENCES Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, for the DIAMOND Study Group. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections. The DIAMOND Randomized Clinical Trial. JAMA. 2017;317(4): doi: /jama Feig D, et al "Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicenter international randomized controlled trial" The Lancet 2017; DOI: /S (17) Garg, Satish K. & Polsky, Sarit "Continuous glucose monitoring in pregnant women with type 1 diabetes" The Lancet 2017; DOI: / S (17) Practice Bulletin No. 180: Gestational Diabetes Mellitus. Obstetrics & Gynecology, vol. 130, no. 1, 2017, pp. e17 e37., doi: /aog Stewart, Zoe A., et al. Closed Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes. The New England Journal of Medicine, vol. 375, no. 7, 2016, pp , doi: /nejmoa

4/2/2018 MOVING THROUGH PREGNANCY WITH TECHNOLOGY CLINICAL EXPERIENCE WITH PUMPS, CGMS AND THE HYBRID CLOSED LOOP CONFLICT OF INTEREST DISCLOSURE

4/2/2018 MOVING THROUGH PREGNANCY WITH TECHNOLOGY CLINICAL EXPERIENCE WITH PUMPS, CGMS AND THE HYBRID CLOSED LOOP CONFLICT OF INTEREST DISCLOSURE MOVING THROUGH PREGNANCY WITH TECHNOLOGY CLINICAL EXPERIENCE WITH PUMPS, CGMS AND THE HYBRID CLOSED LOOP Alyson Blum, PharmD, CDE Clinical Pharmacist in Obstetrics Center for Maternal Fetal Medicine at

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the

More information

Current Trends in Diagnosis and Management of Gestational Diabetes

Current Trends in Diagnosis and Management of Gestational Diabetes Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives

More information

Vishwanath Pattan Endocrinology Wyoming Medical Center

Vishwanath Pattan Endocrinology Wyoming Medical Center Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected

More information

NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP

NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at

More information

Diabetes Related Disclosures

Diabetes Related Disclosures Diabetes Related Disclosures Speakers Bureau Amylin Boehringer Ingelheim Eli Lilly Takeda Classification of Diabetes Diabetes Care January 2011 vol. 34 no. Supplement 1 S11-S61 Type 1 Diabetes Mellitus

More information

Management of Pregestational and Gestational Diabetes Mellitus

Management of Pregestational and Gestational Diabetes Mellitus Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is

More information

Updates in Diabetes Technology

Updates in Diabetes Technology Updates in Diabetes Technology Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO No disclosures Disclosures 1 Objectives Distinguish patients appropriate for continuous glucose monitoring and insulin

More information

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Resident School November 5 2014 Goals Be able to screen for gestational and preexisting diabetes Be able to counsel women on the diagnosis of gestational diabetes Understand glucose

More information

APEC Guidelines Gestational Diabetes Mellitus

APEC Guidelines Gestational Diabetes Mellitus Gestational diabetes mellitus (GDM) is defined as insulin resistance of variable severity with onset or first recognition during pregnancy. The prevalence of diabetes mellitus (DM) in the US is growing

More information

Diabetes in obstetric patients

Diabetes in obstetric patients Diabetes in obstetric patients Swedish Society of Obstetric Anaesthesia & Intensive Care Anita Banerjee Obstetric Physician Diabetes & Endocrinology Consultant Outline Scope of the problem Diabetes and

More information

Insulin Prior Authorization with optional Quantity Limit Program Summary

Insulin Prior Authorization with optional Quantity Limit Program Summary Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Gestational Diabetes. A Guide for Pregnant Women

Gestational Diabetes. A Guide for Pregnant Women August 2009 fast facts n Gestational diabetes is a kind of diabetes that can happen during pregnancy. It usually goes away after delivery. n Gestational diabetes is treated by controlling blood sugar.

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe

More information

Rev. date Kaiser Foundation Health Plan of Washington

Rev. date Kaiser Foundation Health Plan of Washington PE3620000-01-17 Rev. date 2014013 2017 Kaiser Foundation Health Plan of Washington Gestational diabetes Information to help you stay healthy during your pregnancy What is gestational diabetes? How gestational

More information

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese

More information

10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:

10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD: DEXCOM G5 MOBILE CGM COMPATIBLE B 100% 235 u INSULIN ON BOARD: OPTIONS 10:20 AM March 5, 2017 400 350 300 250 200 150 100 50 1.1 u 1:09 hrs BOLUS 124 mg/dl 3 HRS The pump that gets updated, not outdated.

More information

Pediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services

Pediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services 1.19.18 Pediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services DISCLOSURES 1. No financial incentives 2. Volunteer Positions 1. National Certification Board

More information

Diabetes in Pregnancy. L.Sekhavat MD

Diabetes in Pregnancy. L.Sekhavat MD Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes

More information

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections 8/5/217 The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections Richard M. Bergenstal, MD Executive Director International Diabetes Center at Park Nicollet Minneapolis,

More information

As of June 2015 in the United

As of June 2015 in the United Insulin Use in Pregnancy: An Update Alyson K. Blum IN BRIEF Insulin remains the standard of care for the treatment of type 1 diabetes, type 2 diabetes, and uncontrolled gestational diabetes. Tight control

More information

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction

More information

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest. Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives

More information

Gestational Diabetes. Gestational Diabetes:

Gestational Diabetes. Gestational Diabetes: Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,

More information

4/2/2018. Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE. I have no conflicts of interest to disclose

4/2/2018. Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE. I have no conflicts of interest to disclose Easing the pharmacy experience and stretching the diabetes dollar. Alyson Blum, PharmD, CDE Clinical Pharmacist in Obstetrics Center for Maternal Fetal Medicine at Sacred Heart Medical Center Clinical

More information

Nph insulin conversion to lantus

Nph insulin conversion to lantus Nph insulin conversion to lantus Search 26-2-2003 RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin.

More information

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network Gestational Diabetes Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network Outline Definition Prevalence Risk factors complications Diagnosis Management Nonpharmacologic

More information

Continuous Glucose Monitoring

Continuous Glucose Monitoring Continuous Glucose Monitoring What is Continuous Glucose Monitoring? Blood glucose meters measure glucose in your blood and glucose sensors measure glucose levels in the fluid around the cells They are

More information

National Aboriginal Diabetes Association. Gestational Diabetes (developed by Sarah Smith, 4 th yr Nursing, University of Manitoba)

National Aboriginal Diabetes Association. Gestational Diabetes (developed by Sarah Smith, 4 th yr Nursing, University of Manitoba) National Aboriginal Diabetes Association Gestational Diabetes (developed by Sarah Smith, 4 th yr Nursing, University of Manitoba) Who we are NADA is a not-for-profit members-led organization established

More information

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set

More information

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines

More information

Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome

Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology

More information

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn

More information

8/21/2017 UNRAVELING THE CROWED INSULIN SCENE. A Practical Overview of Insulin Focusing on New Insulin Preparations

8/21/2017 UNRAVELING THE CROWED INSULIN SCENE. A Practical Overview of Insulin Focusing on New Insulin Preparations UNRAVELING THE CROWED INSULIN SCENE A Practical Overview of Insulin Focusing on New Insulin Preparations Patricia Garnica MS, ANP-BC, CDE, CDTC North Shore University Hospital, Manhasset, N.Y. October

More information

Pregestational Diabetes in Pregnancy. An Update

Pregestational Diabetes in Pregnancy. An Update Pregestational Diabetes in Pregnancy An Update Disclosures D. Ware Branch, MD Nothing to disclose Questions to Be Addressed What are risks factors for adverse pregnancy outcome in pregestational diabetes?

More information

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ) Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min

More information

Diabetes: We ve Come a Long Way, Baby! Amy Wachter, MD Christiana Care Endocrinology March 22, 2018

Diabetes: We ve Come a Long Way, Baby! Amy Wachter, MD Christiana Care Endocrinology March 22, 2018 Diabetes: We ve Come a Long Way, Baby! Amy Wachter, MD Christiana Care Endocrinology March 22, 2018 Title of My Talk Ancient Times Diabetes has been affecting lives for thousands of years. Egyptians in

More information

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Management of Diabetes New Concepts New Devices New Medications Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Objectives: At the end of this lecture, the learner will

More information

Significant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance

Significant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance What s New in Gestational Diabetes? Diane Reader RD, CDE International Diabetes Center Park Nicollet Health Services Minneapolis, MN GDM Statistics What s New? Proposed Changes to Diagnostic Criteria Treatment

More information

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT

More information

Diabetes in Pregnancy: Detection, Intervention, Prevention. Diabetes in Pregnancy: Outline. Diabetes in Pregnancy

Diabetes in Pregnancy: Detection, Intervention, Prevention. Diabetes in Pregnancy: Outline. Diabetes in Pregnancy Diabetes in Pregnancy: Detection, Intervention, Prevention Michael Shannon, MD Chair, Providence Endocrinology/Diabetes CAT Diabetes in Pregnancy: Outline Prevalence, Pathophysiology and Complications

More information

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION Jaiwant Rangi, MD, FACE Nov 10 th 2018 DISCLOSURES Speaker Novo Nordisk Sanofi-Aventis Boheringer Ingleheim Merck Abbvie Abbott

More information

Diabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018

Diabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Diabetes Technology Update Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Disclosures None No future technologies are FDA approved Continuous Glucose Monitors Continuous Glucose Monitors

More information

What is Diabetes Mellitus?

What is Diabetes Mellitus? Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates

More information

Initiating Injectable Therapy in Type 2 Diabetes

Initiating Injectable Therapy in Type 2 Diabetes Initiating Injectable Therapy in Type 2 Diabetes David Doriguzzi, PA C Learning Objectives To understand current Diabetes treatment guidelines To understand how injectable medications fit into current

More information

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)

More information

Diabetes Head to Toe May 31, 2017

Diabetes Head to Toe May 31, 2017 Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing

More information

GESTATIONAL DIABETES TESTING AND TREAMENT

GESTATIONAL DIABETES TESTING AND TREAMENT Boston Medical Center Maternity Care Guideline: GESTATIONAL DIABETES TESTING AND TREAMENT Accepted: August 2015 Updated: December 2018 Contributors: Aviva Lee-Parritz, MD, Sara Alexanian, MD, Kari Radoff,

More information

Lantus to levemir conversion

Lantus to levemir conversion Lantus to levemir conversion The Borg System is 100 % Lantus to levemir conversion 16-6-2005 Ask the Expert on... Lantus Conversion. Karen Shapiro, PharmD, BCPS. Disclosures. June 16, 2005. Question. Would

More information

Type I Type II Insulin Resistance

Type I Type II Insulin Resistance Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100

More information

Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?

Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Alan B Schorr DO FAAIM FACE www.sugardoc.com abs@sugardoc.com Disclosures

More information

Mixed Insulins Pick Me

Mixed Insulins Pick Me Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing

More information

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.

More information

Diabetes School October 2016

Diabetes School October 2016 Diabetes School October 2016 Name Change- Why? Shorter Has my name in it Emphasizes a major part of the practice Still see non-research patients Novo Nordisk Lilly sanofi aventis! Thank You to our LucasResearch

More information

Managing Gestational Diabetes. Definition of GDM

Managing Gestational Diabetes. Definition of GDM Managing Gestational Diabetes Definition of GDM Gestational diabetes is defined as glucose intolerance of variable severity with onset or first recognition during pregnancy that excludes those with overt

More information

DIABETES WITH PREGNANCY

DIABETES WITH PREGNANCY DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal

More information

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.

More information

Insulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018

Insulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018 Insulins: Prices, Rebates, and Other Factors Influencing Costs May 2018 Introduction: Types of Insulin Types of Insulin Rapid-acting: Usually taken before a meal to cover the blood glucose elevation from

More information

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17 Objectives Compare and contrast currently available products. Navigating New s Diana Isaacs, PharmD, BCPS, BC-ADM, CDE Clinical Pharmacy Specialist Cleveland Clinic Diabetes Center Determine the factors

More information

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Newer Insulins Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Luigi F. Meneghini, MD, MBA Professor of Internal Medicine, UT Southwestern Medical Center Executive Director, Global

More information

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy Objectives Diabetes and Obesity in Pregnancy. Health Impact for the mother and child Bresta Miranda, MD Assistant Professor of Clinical Medicine University of Miami, Miller School of Medicine Review physiologic

More information

Case Study: Competitive exercise

Case Study: Competitive exercise Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia

More information

Management of Gestational Diabetes

Management of Gestational Diabetes Management of Gestational Diabetes A Diabetes risk assessment should be ascertained at the First prenatal visit. Low Risk: Early blood glucose screening is NOT routinely required if most of the following

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES Generic Brand HICL GCN Exception/Other INSULIN REGULAR, HUMAN AFREZZA 37619, 37622, 37623, 38923, 37624, 42833, 38918, 37621 GUIDELINES FOR USE 1. Is the member currently taking the requested medication

More information

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Pumps & Sensors & Meters, Oh My! A Tale of Two Meters Technology for glucometers

More information

Inpatient Glycemic Management:

Inpatient Glycemic Management: Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures: Dr. Seley attended Advisory Board Meeting: Alliance (Boehringer-Ingelheim/Lilly) Bayer Diabetes Care Sanofi

More information

第十五章. Diabetes Mellitus

第十五章. Diabetes Mellitus Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances

More information

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial Dr Sandra Neoh on behalf of: Dr Denice Feig and Professor Helen Murphy Funders: JDRF (Juvenile Diabetes Research Foundation),

More information

Drug Effectiveness Review Project Summary Report Long acting Insulins

Drug Effectiveness Review Project Summary Report Long acting Insulins Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

The Ever-Changing Approaches to Diabetes in Pregnancy

The Ever-Changing Approaches to Diabetes in Pregnancy The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches

More information

Learning Objectives. Are you ready for more insulin formulations?

Learning Objectives. Are you ready for more insulin formulations? Are you ready for more insulin formulations? Shara Elrod, PharmD, BCACP, BCGP Learning Objectives Review pharmacology and dosing of new insulin formulations Compare and contrast new insulin formulations

More information

Lantus levemir conversion

Lantus levemir conversion Lantus levemir conversion Search Learn about starting insulin-naïve patients with type 2 diabetes on Levemir. Read Important Safety & Prescribing Info on the HCP Website. Lantus and Levemir have a variety

More information

Adjusting Insulin Doses

Adjusting Insulin Doses Adjusting Insulin Doses Everyone with diabetes, including you, will need to adjust your insulin doses at some time. There are several reasons why a person may need an insulin adjustment. These reasons

More information

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January Basal-Bolus Insulin Therapy Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January 18 2018 Terminology No longer using the term diabetic. Diabetes does not define people. People with diabetes are individuals

More information

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate Reviewing Diabetes Guidelines Newsletter compiled by Danny Jaek, Pharm.D. Candidate AL AS KA N AT IV E DI AB ET ES TE A M Volume 6, Issue 1 Spring 2011 Dia bet es Dis pat ch There are nearly 24 million

More information

The Signs, Symptoms, and Causes of Hypoglycemia

The Signs, Symptoms, and Causes of Hypoglycemia The Signs, Symptoms, and Causes of Hypoglycemia Tam Doan PharmD, CDE, BC-ADM Clinical Pharmacist, Diabetes Care Manager Santa Clara Valley Medical Center Fruitdale, CA Agenda What is hypoglycemia? What

More information

CommUnityCare Women s Health Brackenridge Professional Office Building

CommUnityCare Women s Health Brackenridge Professional Office Building Guidelines for Diabetes in Pregnancy Effective Date 7/1/11 *This document does not define a standard of care, nor is it intended to dictate an exclusive course of management. There are other accepted strategies

More information

Chapter 14 Elderly, Home and Long-term Care Collections. Objectives:

Chapter 14 Elderly, Home and Long-term Care Collections. Objectives: EXERCISE 11: BEDSIDE GLUCOSE TESTING Textbook: Skills: Chapter 14 Elderly, Home and Long-term Care Collections 15 points Objectives: 1. Define diabetes mellitus. 2. Compare and contrast: Type 1 Diabetes,

More information

The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy. Today s Presenter

The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy. Today s Presenter FD Title Slide The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy learn.extension.org/events/3369 3 This material is based upon work supported by the National Institute

More information

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal

More information

Insulin Regimens: Hitting Glycemia Targets

Insulin Regimens: Hitting Glycemia Targets Insulin Regimens: Hitting Glycemia Targets Grant Kelley MD March 1 st, 2018 Faculty Disclosure: Financial relationships with commercial interests None Overview Mortality and Morbidity Insulin and Insulin

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 57 Effective Health Care Program Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is

More information

QUICK TIP GUIDE: DIABETES SHNIC

QUICK TIP GUIDE: DIABETES SHNIC QUICK TIP GUIDE: DIABETES SHNIC The body The digestive tract breaks down carbs into glucose. Glucose is a form of sugar that enters the bloodstream. Insulin, a hormone, then helps cells in the body to

More information

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized

More information

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Pathogenesis of Diabetes Mellitus (DM) Criteria for the diagnosis

More information

Learning Objectives. Perioperative SWEET Success

Learning Objectives. Perioperative SWEET Success Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies Advances in Diabetes Care Technologies 1979 2015 Introduction Roughly 20% to 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the U.S. FDA

More information

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia) How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

Insulin Therapy Management. Insulin Therapy

Insulin Therapy Management. Insulin Therapy Insulin Therapy Management Insulin Therapy Contents Insulin and its effect on glycemic control Physiology of insulin secretion Insulin pharmacokinetics and regimens Insulin dose adjustment for pregnancy

More information

Maternal and Fetal Complications in Diabetes Pregnancy

Maternal and Fetal Complications in Diabetes Pregnancy Maternal and Fetal Complications in Diabetes Pregnancy Helen R Murphy Professor of Medicine (Diabetes & Antenatal Care), UEA Professor of Women s Health, Kings College London hm386@medschl.cam.ac.uk 1

More information

Real-time Continuous Glucose Recording: An analysis of end user self-reported experiences

Real-time Continuous Glucose Recording: An analysis of end user self-reported experiences Real-time Continuous Glucose Recording: An analysis of end user self-reported experiences Author: Tim Street Abstract Objective: This study analyzed user's views on their use of real-time continuous glucose

More information

DIABETES TECHNOLOGY: ENDLESS CHOICES FOR HEALTHY MANAGEMENT

DIABETES TECHNOLOGY: ENDLESS CHOICES FOR HEALTHY MANAGEMENT DIABETES TECHNOLOGY: ENDLESS CHOICES FOR HEALTHY MANAGEMENT MAKING THE MOST OF MODERN DIABETES TREATMENTS & TECHNOLOGIES JENNIFER C. SMITH RD, LD, CDE DIRECTOR OF LIFESTYLE AND NUTRITION INTEGRATED DIABETES

More information

Blood Sugar and Insulin

Blood Sugar and Insulin PATIENT & CAREGIVER EDUCATION Blood Sugar and Insulin This information explains high and low blood sugar levels and how to manage them. About Blood Sugar and Insulin Your body uses a sugar called glucose

More information

January 7, 5:00 p.m. EST

January 7, 5:00 p.m. EST Study 3-151 Phase 2 Trial: Preliminary Results BIOD-531, a Concentrated Ultra-Rapid-Acting Prandial/Basal Insulin, Demonstrates Superior Post-Meal Glucose Control Compared to Marketed Prandial/Basal Insulins

More information

Pumping Insulin is it for your patients?

Pumping Insulin is it for your patients? Pumping Insulin is it for your patients? YOU CAN make managing diabetes easier. Fred Porcase D.O. Disclosures to Participants Conflicts Of Interest and Financial Relationships Disclosures: No professional

More information

CANDY Camp Application

CANDY Camp Application CANDY Camp Application Please complete the following form and submit it by June 15, 2016. Please mail form to Bonnie Kruse, Diabetes Program Coordinator, HSHS St. Anthony s Memorial Hospital, 503 North

More information

Objectives. Diabetes in Pregnancy: A Growing Dilemma. Diabetes in the US 10/6/2015. Disclosure. The presenter has no conflicts to disclose

Objectives. Diabetes in Pregnancy: A Growing Dilemma. Diabetes in the US 10/6/2015. Disclosure. The presenter has no conflicts to disclose Diabetes in Pregnancy: A Growing Dilemma Kathy O Connell, MN RN Perinatal Clinical Nurse Specialist University of Washington Medical Center Seattle, WA koconnll@uw.edu Objectives Describe pathophysiologic

More information